JP2019536015A5 - - Google Patents

Download PDF

Info

Publication number
JP2019536015A5
JP2019536015A5 JP2019523046A JP2019523046A JP2019536015A5 JP 2019536015 A5 JP2019536015 A5 JP 2019536015A5 JP 2019523046 A JP2019523046 A JP 2019523046A JP 2019523046 A JP2019523046 A JP 2019523046A JP 2019536015 A5 JP2019536015 A5 JP 2019536015A5
Authority
JP
Japan
Prior art keywords
patent document
application
prior
documents cited
document
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019523046A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019536015A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/058276 external-priority patent/WO2018081262A1/en
Publication of JP2019536015A publication Critical patent/JP2019536015A/ja
Publication of JP2019536015A5 publication Critical patent/JP2019536015A5/ja
Pending legal-status Critical Current

Links

JP2019523046A 2016-10-26 2017-10-25 良性腫瘍ではなく悪性腫瘍を標的とし、かつ結合する検出可能な分子 Pending JP2019536015A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662412948P 2016-10-26 2016-10-26
US62/412,948 2016-10-26
PCT/US2017/058276 WO2018081262A1 (en) 2016-10-26 2017-10-25 Detectable molecules that target and bind to malignant tumors and not benign tumors

Publications (2)

Publication Number Publication Date
JP2019536015A JP2019536015A (ja) 2019-12-12
JP2019536015A5 true JP2019536015A5 (enExample) 2020-10-08

Family

ID=62025452

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019523046A Pending JP2019536015A (ja) 2016-10-26 2017-10-25 良性腫瘍ではなく悪性腫瘍を標的とし、かつ結合する検出可能な分子

Country Status (4)

Country Link
US (1) US20190255195A1 (enExample)
JP (1) JP2019536015A (enExample)
CN (1) CN109982721A (enExample)
WO (1) WO2018081262A1 (enExample)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040047804A1 (en) * 1998-10-29 2004-03-11 The General Hospital Corporation, A Massachusetts Corporation Enhanced radiation therapy
WO2011148371A1 (en) * 2010-05-23 2011-12-01 Technion Research And Development Foundation Ltd. Detection, staging and grading of benign and malignant tumors
CN102372771A (zh) * 2010-08-26 2012-03-14 杨静雯 一种肿瘤靶向分子及其应用
WO2014074805A1 (en) * 2012-11-08 2014-05-15 Whitehead Institute For Biomedical Research Selective targeting of cancer stem cells
CN104892820B (zh) * 2015-05-11 2017-08-04 厦门大学 一种受体类分子靶向显像剂及其制备方法

Similar Documents

Publication Publication Date Title
JP2019502892A5 (enExample)
JP2014528601A5 (enExample)
JP2014513356A5 (enExample)
JP2013540292A5 (enExample)
JP2013517798A5 (enExample)
JP2017505048A5 (enExample)
JP2020512939A5 (enExample)
JP2016523701A5 (enExample)
PH12018501778A1 (en) Antibodies to tigit
JP2022541589A5 (enExample)
JP2020530380A5 (enExample)
JP2015531923A5 (enExample)
CN110214154A (zh) 抗cd47抗体及其用途
CY1117236T1 (el) Μονοκλωνικα αντισωματα εναντι γλυπικανης-3
JP2018525453A5 (enExample)
JP2019502069A5 (enExample)
JP2018520447A5 (enExample)
JP2016506890A5 (enExample)
JP2016506366A5 (enExample)
JP2023502438A5 (enExample)
HUS1800021I1 (hu) Humán anti-Il-23 ellenanyagok, készítmények, eljárások és alkalmazások
JP2016527801A5 (enExample)
JP2017527742A5 (enExample)
KR20220016865A9 (ko) 항원 결합 분자, 약학 조성물, 및 방법
ATE455791T1 (de) T-cd4+-epitope der latenzantigene typ i und ii des epstein-barr-virus, die bei der mehrzahl von individuen in der kaukasischen bevölkerung erkannt werden können, und anwendungen davon